Skjødt, Michael Kriegbaum http://orcid.org/0000-0002-2109-8989
Nicolaes, Joeri http://orcid.org/0000-0003-2789-8781
Smith, Christopher Dyer
Olsen, Kim Rose
Libanati, Cesar
Cooper, Cyrus
Abrahamsen, Bo http://orcid.org/0000-0002-2730-6080
Funding for this research was provided by:
Region Zealand Health Scientific Research Foundation
UCB Pharma / Amgen Inc
Zealand Region
Article History
Received: 19 February 2023
Accepted: 3 January 2024
First Online: 18 January 2024
Declarations
: All authors had full access to the study results, and assumes responsibility for the decision to submit for publication.
: MKS and BA have received support for this study from UCB/Amgen and Region Zealand Health Scientific Research Foundation (research grants with funds paid to the institution); MKS has received support from the University of Southern Denmark (PhD scholarship), UCB (educational grant) outside the submitted work, UCB Nordic (personal speaker fees), is a board member of the Danish Bone Society, and a member of working groups in the Danish Bone Society and the European Calcified Tissue Society; JN and CL are employees of UCB Pharma with stock ownership, and JN is involved in a patent (11341639) and has received support for travel from UCB Pharma; CDS and KRO have no conflicts to report; CC has received personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB; BA has received personal speakers fees/consulting fees from UCB, Amgen, Kyowa-Kirin, and Pharmacosmos, and institutional research grants (with funds paid to the institution) from Novartis, Kyowa-Kirin, and Pharmacosmos, and is the past-president of the European Calcified Tissue Society.